WHO ICTRP trial
Bioequivalence Study of Combination-ACC007 Tablets in Human
ChiCTR1900028166 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900028166 |
|---|---|
| Public title | Bioequivalence Study of Combination-ACC007 Tablets in Human |
| Scientific title | A randomized, open-label, double-cycle and double-crossover trial for fasting bioequivalence of combination-ACC007 tablets and at the same time ACC007 tablets, lamivudine tablets and tenofovir dipivoxil fumarate tablets were given in healthy volunteers |
| Primary sponsor | Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | HIV/ADIS |
| Interventions | Group T-R:Tablet; Specification: Each tablet contains 150 mg of ACC007, 300 mg of lamivudine and 300 mg of tenofovir fumarate; it is orally administered on an empty stomach, 1 tablet per cycle, 2 cycles in total.;Group R-T:Tablet… |
| Registration date | Dec 14, 2019 |
| Target size | Group T-R:24;Group R-T:24 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: